Spots Global Cancer Trial Database for pimivalimab
Every month we try and update this database with for pimivalimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors | NCT04669899 | Cancer | JTX-8064 pimivalimab | 18 Years - | Jounce Therapeutics, Inc. | |
Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors | NCT04669899 | Cancer | JTX-8064 pimivalimab | 18 Years - | Jounce Therapeutics, Inc. | |
Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen | NCT04549025 | NSCLC | Pimivalimab Vopratelimab | 18 Years - | Jounce Therapeutics, Inc. |